CD34+ -derived CD11c+++ BDCA-1++ CD123 ++ DC: Expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy

Cytotherapy

Volumn 8, Issue 2, 2006, Pages 130-140

  Ward, Kate A ^a,b   Stewart, L A ^a   Schwarer, A P ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

CD123; DC1; DC2; Dendritic cells; Immunotherapy

Indexed keywords

B7 ANTIGEN; CD123 ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CELL MARKER; CYTOKINE; FLT3 LIGAND; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY; PROSTAGLANDIN E2; STEM CELL FACTOR; TETANUS TOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; BONE MARROW CELL; CELL ASSAY; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CELL STRUCTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANTIGENS, CD; ANTIGENS, CD11C; ANTIGENS, CD34; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DINOPROSTONE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; RECEPTORS, INTERLEUKIN-3; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646399195     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240600620689     Document Type: Article

References (30)

1. MacDonald, KP and Munster, DJ and Clark, GJ and (2002) Characterization of human blood dendritic cell subsets Blood, 100, pp. 4512-20.
2. Dzionek, A and Fuchs, A and Schmidt, P and (2000) BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood J Immunol, 165, pp. 6037-46.
3. O'Neill, DW and Adams, S and Bhardwaj, N. (2004) Manipulating dendritic cell biology for the active immunotherapy of cancer Blood, 104, pp. 2235-46.
4. + hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells J Immunol, 173, pp. 2780-91.
5. Lopez, JA and Bioley, G and Turtle, CJ and (2003) Single step enrichment of blood dendritic cells by positive immunoselection J Immunol Methods, 274, pp. 47-61.
6. + monocytes for anti-tumor immunotherapy Leuk Lymphoma, 45, pp. 1419-28.
7. Holtl, L and Ramoner, R and Zelle-Rieser, C and (2005) Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide Cancer Immunol Immunother, 54, pp. 663-70.
8. Banchereau, J and Palucka, AK and Dhodapkar, M and (2001) Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine Cancer Res, 61, pp. 6451-8.
9. Rice, AM and Jones, KL and Hart, DN. (2004) DC preparations for therapy Cytotherapy, 6, pp. 99-104.
10. + progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis Klin Padiatr, 216, pp. 176-82.
11. Ishri, RK and Menzies, S and Hersey, P and Halliday, GM. (2004) Rapid downregulation of antigen processing enzymes in ex vivo generated human monocyte derived dendritic cells occur endogenously in extended cultures Immunol Cell Biol, 82, pp. 239-46.
12. Jakobsen, MA and Moller, BK and Lillevang, ST. (2004) Serum concentration of the growth medium markedly affects monocyte-derived dendritic cells' phenotype, cytokine production profile and capacities to stimulate in MLR Scand J Immunol, 60, pp. 584-91.
13. Mackensen, A and Herbst, B and Chen, JL and (2000) Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells Int J Cancer, 86, pp. 385-392.
14. Pietschmann, P and Stockl, J and Draxler, S and (2000) Functional and phenotypic characteristics of dendritic cells generated in human plasma supplemented medium Scand J Immunol, 51, pp. 377-83.
15. + peripheral blood dendritic cells are differentially regulated by cytokines J Immunol, 163, pp. 3250-9.
16. Lock, K and Zhang, J and Lu, J and Lee, SH and Crocker, PR. (2004) Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells Immunobiology, 209, pp. 199-207.
17. Ohana-Malka, O and Benharroch, D and Isakov, N and (2003) Selectins and anti-CD15 (Lewis x/a) antibodies transmit activation signals in Hodgkin's lymphoma-derived cell lines Exp Hematol, 31, pp. 1057-65.
18. Ojcius, DM and Niedergang, F and Subtil, A and (1996) Immunology and the confocal microscope Res Immunol, 147, pp. 175-88.
19. Todorova, K and Ignatova, I and Tchakarov, S and (2005) Humoral immune response in prostate cancer patients after immunization with gene-based vaccines that encode for a protein that is proteasomally degraded Cancer Immun, 5, pp. 1-8.
20. Syme, R and Callaghan, D and Duggan, P and (2002) Storage of blood for in vitro generation of dendritic cells Cytotherapy, 4, pp. 271-6.
21. Thurner, B and Roder, C and Dieckmann, D and (1999) Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application J Immunol Methods, 223, pp. 1-15.
22. + subset of human blood dendritic cells is a direct precursor of Langerhans cells J Immunol, 163, pp. 1409-19.
23. Thomas, R and Lipsky, PE. (1994) Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells J Immunol, 153, pp. 4016-28.
24. Syme, R and Bajwa, R and Robertson, L and (2005) Comparison of CD34 and monocyte-derived dendritic cells from mobilized peripheral blood from cancer patients Stem Cells, 23, pp. 74-81.
25. + hematopoietic progenitor cells Blood, 87, pp. 1292-302.
26. + hematopoietic progenitor cells of the bone marrow and peripheral blood Cancer Res, 55, pp. 1099-104.
27. Liu, YJ. (2001) Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity Cell, 106, pp. 259-62.
28. Osugi, Y and Vuckovic, S and Hart, DN. (2002) Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes Blood, 100, pp. 2858-66.
29. Buelens, C and Bartholome, EJ and Amraoui, Z and (2002) Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties Blood, 99, pp. 993-8.
30. Strobl, H and Bello-Fernandez, C and Riedl, E and (1997) Flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions Blood, 90, pp. 1425-34.